Company
Biocytogen
Your Partner from Targets to Therapeutics
Also known as Biocytogen Boston Corp
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Beijing, China
- Customers
- clients worldwide
- Legal name
- Biocytogen Boston Corp
- biocytogen.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
Biocytogen (SSE: 688796; HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies.
Funding snapshot
- Latest round
- Undisclosed2021-06
Funding rounds
- Round, 2021
- 2021-06
- Series D+
- 2020-09
- Series D+
- 2019-07
- Series C
- 2018-04
- Series B
- 2015
Loading relationship preview